DK8492D0 - TREATMENT OF PSYCHOSIS - Google Patents

TREATMENT OF PSYCHOSIS

Info

Publication number
DK8492D0
DK8492D0 DK9284A DK8492A DK8492D0 DK 8492 D0 DK8492 D0 DK 8492D0 DK 9284 A DK9284 A DK 9284A DK 8492 A DK8492 A DK 8492A DK 8492 D0 DK8492 D0 DK 8492D0
Authority
DK
Denmark
Prior art keywords
psychosis
treatment
Prior art date
Application number
DK9284A
Other languages
Danish (da)
Inventor
Kim Andersen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Priority to DK9284A priority Critical patent/DK8492D0/en
Publication of DK8492D0 publication Critical patent/DK8492D0/en
Priority to EP93903188A priority patent/EP0621781A1/en
Priority to CA002128699A priority patent/CA2128699A1/en
Priority to CZ941764A priority patent/CZ176494A3/en
Priority to JP5512865A priority patent/JPH07503240A/en
Priority to AU34494/93A priority patent/AU670063B2/en
Priority to SK863-94A priority patent/SK86394A3/en
Priority to PCT/DK1993/000021 priority patent/WO1993014758A1/en
Priority to ZA93491A priority patent/ZA93491B/en
Priority to NO942686A priority patent/NO942686L/en
Priority to RU94035658/14A priority patent/RU94035658A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
DK9284A 1992-01-23 1992-01-23 TREATMENT OF PSYCHOSIS DK8492D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DK9284A DK8492D0 (en) 1992-01-23 1992-01-23 TREATMENT OF PSYCHOSIS
ZA93491A ZA93491B (en) 1992-01-23 1993-01-22 Treatment of psychoses
JP5512865A JPH07503240A (en) 1992-01-23 1993-01-22 Use of 3-arylindole and 1-arylindazole derivatives for the treatment of psychosis
CA002128699A CA2128699A1 (en) 1992-01-23 1993-01-22 Use of 3-arylindole and 3-arylindazole derivatives for the treatment of psychoses
CZ941764A CZ176494A3 (en) 1992-01-23 1993-01-22 The use of 3-arylindole and 3-arylindazole derivative for preparing pharmaceutical preparations for treating psychoses
EP93903188A EP0621781A1 (en) 1992-01-23 1993-01-22 Use of 3-arylindole and 3-arylindazole derivatives for the treatment of psychoses
AU34494/93A AU670063B2 (en) 1992-01-23 1993-01-22 Use of 3-arylindole and 3-arylindazole derivatives for the treatment of psychoses
SK863-94A SK86394A3 (en) 1992-01-23 1993-01-22 3-arylindole and 3-arylindazole derivatives and their use
PCT/DK1993/000021 WO1993014758A1 (en) 1992-01-23 1993-01-22 Use of 3-arylindole and 3-arylindazole derivatives for the treatment of psychoses
NO942686A NO942686L (en) 1992-01-23 1994-07-18 Use of 3-arylindole and 3-arylindazole derivatives in the treatment of psychoses
RU94035658/14A RU94035658A (en) 1992-01-23 1994-07-22 Use of 3-arylindole and 3-arylindazole derivatives for psychosis treatment, method of treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK9284A DK8492D0 (en) 1992-01-23 1992-01-23 TREATMENT OF PSYCHOSIS

Publications (1)

Publication Number Publication Date
DK8492D0 true DK8492D0 (en) 1992-01-23

Family

ID=8089556

Family Applications (1)

Application Number Title Priority Date Filing Date
DK9284A DK8492D0 (en) 1992-01-23 1992-01-23 TREATMENT OF PSYCHOSIS

Country Status (11)

Country Link
EP (1) EP0621781A1 (en)
JP (1) JPH07503240A (en)
AU (1) AU670063B2 (en)
CA (1) CA2128699A1 (en)
CZ (1) CZ176494A3 (en)
DK (1) DK8492D0 (en)
NO (1) NO942686L (en)
RU (1) RU94035658A (en)
SK (1) SK86394A3 (en)
WO (1) WO1993014758A1 (en)
ZA (1) ZA93491B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK206591D0 (en) * 1991-12-23 1991-12-23 Lundbeck & Co As H TREATMENT OF PSYCHOSIS
WO1998054168A1 (en) * 1997-05-30 1998-12-03 Banyu Pharmaceutical Co., Ltd. 2-oxoimidazole derivatives
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8908085D0 (en) * 1989-04-11 1989-05-24 Lundbeck & Co As H New therapeutic use
DK181190D0 (en) * 1990-07-30 1990-07-30 Lundbeck & Co As H 3-ARYL-INDOL OR 3-ARYL-INDAZOL DERIVATIVES

Also Published As

Publication number Publication date
EP0621781A1 (en) 1994-11-02
JPH07503240A (en) 1995-04-06
AU670063B2 (en) 1996-07-04
CA2128699A1 (en) 1993-08-05
NO942686D0 (en) 1994-07-18
SK86394A3 (en) 1995-04-12
AU3449493A (en) 1993-09-01
CZ176494A3 (en) 1995-04-12
ZA93491B (en) 1993-08-23
NO942686L (en) 1994-07-18
WO1993014758A1 (en) 1993-08-05
RU94035658A (en) 1996-06-20

Similar Documents

Publication Publication Date Title
FI944885A (en) The basic part of the can
FI935223A0 (en) RAKE-mottagare med selective combination of straolar
FI934971A (en) The application of the aid scheme was carried out
FI935135A0 (en) Foerfarande Foer rening of TiO2-malm
NO940190D0 (en) Use of x-ketoglutarate
DK0689577T3 (en) Use of ferronene
MX9102079A (en) PLEMEZCLA OF SEMDURAMICINA
ITPD920013V0 (en) STRAP OF STRAP
MX9206026A (en) RENTAL PROCEDURE OF ISOALCAN-OLEFINAS
DK8492D0 (en) TREATMENT OF PSYCHOSIS
ITMI912654A1 (en) COMBINATION OF EXTRUDER-CALENDER
DK206591D0 (en) TREATMENT OF PSYCHOSIS
NO931399D0 (en) USE OF NATURSTEIN
DK0589626T3 (en) Preparation of beta-methylcarbapenem intermediates
DE69320586D1 (en) Fixing baths
DK36193D0 (en) COURSE OF ACTION
DE69417915D1 (en) PURIFICATION OF URANHEXAFLUORID
KR930026760U (en) Improved configuration of TVCR
DK86992D0 (en) COURSE OF ACTION
DK80592D0 (en) COURSE OF ACTION
DK103092D0 (en) COURSE OF ACTION
LV10073A (en) Influence of Absinthis absolutizesan
KR950029467U (en) Bath of far infrared radiation
SE9201005L (en) crutch
DK143793D0 (en) COURSE OF ACTION

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment